sr141716 has been researched along with Heart Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N; Ghosh, J; Kaye, GC; Nasir, M | 1 |
| Henzen, C | 1 |
| Bátkai, S; Czifra, N; Gerard, NP; Harvey-White, J; Haskó, G; Kunos, G; Liaudet, L; Mukhopadhyay, P; Pacher, P; Rajesh, M; Zsengeller, Z | 1 |
| Bernstein, D; Fajardo, G | 1 |
2 review(s) available for sr141716 and Heart Failure
| Article | Year |
|---|---|
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure.
Topics: Anticoagulants; Cardiology; Clinical Trials as Topic; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Meta-Analysis as Topic; Myocardial Infarction; Pacemaker, Artificial; Piperidines; Platelet Aggregation Inhibitors; Pyrazoles; Rimonabant; United States; Warfarin | 2004 |
[Internal medicine--update 2006].
Topics: Adrenal Gland Neoplasms; Bradykinin; Carotid Stenosis; Clinical Trials as Topic; Contrast Media; Endarterectomy, Carotid; Esophageal and Gastric Varices; Female; Heart Failure; Humans; Hyperglycemia; Hypertension; Hyperthyroidism; Internal Medicine; Male; Middle Aged; Osteitis Deformans; Piperidines; Pulmonary Disease, Chronic Obstructive; Pyrazoles; Renal Insufficiency; Rimonabant; Risk Factors; Stents; Stethoscopes; Weight Loss | 2007 |
3 other study(ies) available for sr141716 and Heart Failure
| Article | Year |
|---|---|
New drugs for prevention, relief. How you might benefit if 3 medications win FDA approval.
Topics: Acetanilides; Angina Pectoris; Benzazepines; Heart Failure; Humans; Obesity; Piperazines; Piperidines; Pyrazoles; Ranolazine; Rimonabant; Tolvaptan | 2005 |
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cannabinoid Receptor Modulators; Cell Line; DNA Fragmentation; Doxorubicin; Heart Failure; Male; Mice; Mice, Inbred C57BL; Morpholines; Myocardium; Myocytes, Cardiac; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2007 |
Endocannabinoid inhibition: a new cardioprotective strategy against doxorubicin cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cannabinoid Receptor Modulators; Doxorubicin; Endocannabinoids; Heart Failure; Morpholines; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2007 |